For media enquiries, call +44 (0)20 7611 8866 or email firstname.lastname@example.org. Contact details for individual media team members are listed below.
We want to help you have conversations with the public about your work. Find out more in our guide to working with the media [PDF 4.6MB].
Researchers at three institutions in the US and UK receive grants to advance studies of repurposed drugs and novel antibodies in preventing COVID-19.
Statements issued by Wellcome in response to the novel coronavirus (COVID-19) pandemic originating in Wuhan, China and its spread to other countries.
More than 25 leading publishers have committed to making all of their COVID-19 and coronavirus-related publications, and the available data supporting them, immediately accessible in PubMed Central and other public repositories.
COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic.
If you have a filming request, please email us.
Our image collections are freely available and licensed under Creative Commons licences. Please check the licence and credit line before downloading an image.
Download copies of the Wellcome logo.